ClearBridge Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

ClearBridge Investments’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-196	Closed	-$9K	–	1018
2020 Q2	$9K	Hold	196	–	–	﹤0.01%	896
2020 Q1	$12K	Sell	196 -6	-3%	-$539	﹤0.01%	933
2019 Q4	$24K	Hold	202	–	–	﹤0.01%	944
2019 Q3	$13K	Hold	202	–	–	﹤0.01%	974
2019 Q2	$16K	Hold	202	–	–	﹤0.01%	963
2019 Q1	$23K	Sell	202 -152	-43%	-$16.6K	﹤0.01%	941
2018 Q4	$36K	Hold	354	–	–	﹤0.01%	890
2018 Q3	$45K	Hold	354	–	–	﹤0.01%	917
2018 Q2	$30K	Sell	354 -489	-58%	-$35.8K	﹤0.01%	929
2018 Q1	$52K	Hold	843	–	–	﹤0.01%	839
2017 Q4	$49K	Hold	843	–	–	﹤0.01%	852
2017 Q3	$49K	Buy	843 +282	+50%	+$30.4K	﹤0.01%	850
2017 Q2	$68K	Buy	561 +23	+4%	+$2.66K	﹤0.01%	809
2017 Q1	$61K	Hold	538	–	–	﹤0.01%	859
2016 Q4	$58K	Buy	538 +15	+3%	+$1.79K	﹤0.01%	874
2016 Q3	$86K	Hold	523	–	–	﹤0.01%	819
2016 Q2	$75K	Buy	523 +272	+108%	+$39.7K	﹤0.01%	837
2016 Q1	$32K	Hold	251	–	–	﹤0.01%	907
2015 Q4	$37K	Hold	251	–	–	﹤0.01%	940
2015 Q3	$42K	Buy	251 +131	+109%	+$28.8K	﹤0.01%	976
2015 Q2	$29K	Sell	120 -60	-33%	-$16K	﹤0.01%	1003
2015 Q1	$51K	Hold	180	–	–	﹤0.01%	963
2014 Q4	$28K	Buy	+180	New	+$33.2K	﹤0.01%	1039

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

ClearBridge Investments's ICPT Position: Q3 2020 in Review

ClearBridge Investments sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 196 shares — an estimated $9K sold.

ClearBridge Investments first reported a position in ICPT in Q4 2014 and held it in 23 quarters. The position peaked at $86K in Q3 2016. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

ClearBridge Investments reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
ClearBridge Investments sold 196 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $9K.
ClearBridge Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 23 quarters.
ClearBridge Investments's Intercept Pharmaceuticals, Inc. position peaked at $86K in Q3 2016.
177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on ClearBridge Investments's 13F filing for Q3 2020, filed 12 Nov 2020.